BioBeats evolves from stress app to measurer of well-being
BioBeats makes apps that apply artificial intelligence in the cloud, looking for what CEO David Plans called "instances of well-being."
BioBeats makes apps that apply artificial intelligence in the cloud, looking for what CEO David Plans called "instances of well-being."
An upcoming randomized controlled trial of BioBeats' stress assessment app will have around 700 corporate users and the trial will follow a cluster randomised controlled trial design, according to co-founder Dr David Plans.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
White Cloud Capital led the fundraise, and AXA Strategic Ventures and IQ Capital, also took part in the round.